Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y
PRGO beats Q1 EPS estimates despite lower sales. Weakness in cough and cold demand offsets gains in Women's Health and Infant Formula.
Open original sourceLoading market dashboard
PRGO beats Q1 EPS estimates despite lower sales. Weakness in cough and cold demand offsets gains in Women's Health and Infant Formula.
Open original source